THE ANALYSIS OF MORPHOFUNCTIONAL CONDITION OF THE UPPER LIMB MUSCLES IN TREATMENT OF PATIENTS WITH POSTTRAUMATIC ELBOW FLEXION-AND-EXTENSION CONTRACTURES

by L. A. Grebenyuk, Y. P. Soldatov
Published 2012-12-01

First experience of using Brentuximab vedotin and modified program NHL-BFM-90 in the front-line treatment of patient with anaplastic large-cell lymphoma: a case report and a review...

by N G CHERNOVA, E E ZVONKOV, D S BADMAZHAPOVA, M N SINITSYNA, L A GREBENYUK, Y V SIDOROVA, I E KOSTINA, A M KOVRIGINA, T N OBUKHOVA, A B SUDARIKOV, V G SAVCHENKO
Published 2018-07-01

Features of cytogenetic diagnosis of simultaneous chronic lymphocytic leukemia and myelodysplastic syndrome: clinical case report

by M. A. Kislitsyna, T. N. Obukhova, A. V. Kokhno, L. A. Grebenyuk, A. V. Luchkin, L. A. Kuzmina, V. N. Dvirnyk, A. M. Kovrigina, I. V. Galtseva, B. V. Biderman, V. V. Troitskaya, E. N. Parovichnikova
Published 2019-10-01

Prognostic value of 1q21 amplification in multiple myeloma

by T V Abramova, T N Obukhova, L P Mendeleeva, O S Pokrovskaya, E O Gribanova, V V Ryzhko, L A Grebenyuk, M V Nareyko, M V Solovyev, O M Votyakova, S M Kulikov, M A Rusinov, V G Savchenko
Published 2017-07-01

Successful experience in treating primary cutaneous anaplastic large cell lymphoma occuring with common lesions of the skin and lung tissue

by N. G. Chernova, D. S. Badmazhapova, A. M. Kovrigina, A. E. Karamova, A. A. Vorontsova, M. N. Sinitcina, Yu. V. Sidorova, L. A. Grebenyuk, M. A. Nefedova, L. F. Znamenskaya, E. E. Zvonkov, V. G. Savchenko
Published 2018-12-01

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry

by O. Yu. Davydova, I. V. Galtseva, E. N. Parovichnikova, A. V. Kokhno, N. M. Kapranov, V. V. Troitskaya, E. A. Mikhailova, Z. T. Fidarova, T. N. Moiseeva, L. A. Kuzmina, E. A. Lukina, T. N. Obukhova, L. A. Grebenyuk, A. M. Kovrigina, V. N. Dvirnyk, V. G. Savchenko
Published 2019-01-01

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy

by O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva
Published 2014-07-01

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy

by O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva
Published 2014-07-01